Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Tomivosertib
Trade Name
Synonyms eFT508|EFT-508
Drug Descriptions

Tomivosertib (eFT508) inhibits MNK1 and MNK2, potentially resulting in decreased tumor cell proliferation and tumor growth, and disrupts translation of PD-L1 (CD274) through inhibition of EIF4E phosphorylation (PMID: 30643286).

DrugClasses MNK1/2 Inhibitor 3
CAS Registry Number 1849590-01-7
NCIT ID C125062


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Avelumab + Tomivosertib Avelumab Tomivosertib 0 1
Azacitidine + Tomivosertib + Venetoclax Azacitidine Tomivosertib Venetoclax 0 1
Paclitaxel + Tomivosertib Paclitaxel Tomivosertib 0 1
Pembrolizumab + Pemetrexed Disodium + Tomivosertib Pembrolizumab Pemetrexed Disodium Tomivosertib 0 1
Pembrolizumab + Tomivosertib Pembrolizumab Tomivosertib 0 1
Tomivosertib Tomivosertib 0 6

Additional content available in CKB BOOST